Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000215 · ClinicalTrials.gov registry record · Phase 2
IV Cocaine Abuse: A Laboratory Model - 4
A Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 2
- Development phase
NCT00000215: Completed Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
NCT00000215 is a Phase 2 study that has completed, run by National Institute on Drug Abuse (NIDA). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000215, a Phase 2 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to evaluate the effects of pergolide on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving in non-opiate dependent cocaine users.
Interventions
- DRUG Pergolide
Trial Details
| Field | Value |
|---|---|
| Est. Completion | 2001-12 |
| Phase | Phase 2 |
What the finished NCT00000215 record still lists
NCT00000215 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Pergolide is the first listed.
NCT00000215 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000215 about?
NCT00000215 is a clinical study titled "IV Cocaine Abuse: A Laboratory Model - 4". The purpose of this study is to evaluate the effects of pergolide on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving in non-opiate dependent cocaine users.
What is the current status of trial NCT00000215?
This trial is currently completed. It is a Phase 2 study. Estimated completion is 2001-12.
What interventions are being tested in trial NCT00000215?
The interventions under investigation include: Pergolide (DRUG).
Who is sponsoring clinical trial NCT00000215?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.